Moderna stock on track for 20% weekly gain after US bird flu death
Moderna (MRNA) was on track to see a weekly gain of 21% as of Wednesday. Shares of the vaccine maker rose 11.7% the prior day following the first reported bird flu death in the US. The stock was up as ...
FDA adds warning to RSV shots from GSK, Pfizer
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.